TG Therapeutics Lands Partner to Market MS Drug in Europe…

Posted by August 1, 2023

A TG Therapeutics multiple sclerosis drug that’s new to the U.S. market will be commercialized in Europe and other regions under a partnership that pays the

Read More

Opthea lines up $260M to show how eye drug compares…

Posted by August 15, 2022

  Current global financial conditions make it difficult for publicly traded biotech companies to raise money through conventional stock offerings, so some co

Read More